Featured Research

from universities, journals, and other organizations

Heart attack research discovers new treatment target

Date:
February 10, 2014
Source:
Louisiana State University Health Sciences Center
Summary:
Research demonstrates for the first time cross-talk between two protective signaling molecules during a heart attack. By providing new and important information about the mechanisms involved in heart attacks and organ transplantation, the research identifies a potential new treatment target for heart disease.

Research led by David Lefer, PhD, Professor and Director of the Cardiovascular Center of Excellence at LSU Health Sciences Center New Orleans School of Medicine, demonstrates for the first time cross-talk between two protective signaling molecules during a heart attack. By providing new and important information about the mechanisms involved in heart attacks and organ transplantation, the research identifies a potential new treatment target for heart disease. The paper will be published in Proceedings of the National Academy of Sciences (PNAS) Online Early Edition the week of February 10, 2014.

Previous studies found that hydrogen sulfide protects cells from damage caused by a number of diseases, including cardiovascular, in a similar manner to that reported for another protective gas, nitric oxide. Though hydrogen sulfide and nitric oxide are biologically similar, it was thought that they protected cells via distinctly different mechanisms. The LSUHSC research team found that instead, they interact and "talk" to each other, and it is this interaction that produces the protective effect during heart attacks.

"We found that hydrogen sulfide regulates the body's production of nitric oxide which, in turn, protects the heart muscle against cell death," notes Dr. Lefer.

Working in a mouse model, the researchers discovered the interdependence between the two molecules. When an enzyme that produces hydrogen sulfide was absent, they found that the production and action of nitric oxide were greatly reduced, resulting in increased oxidative stress and more severe injury to the heart and liver from blocked blood flow as well as from the eventual restoration of blood flow.

"This study has far reaching implications for the development of novel treatments for cardiovascular disease," concludes Dr. Lefer. Although progress has been made, heart disease remains the leading cause of death in the United States. According to the American Heart Association, approximately every 34 seconds, 1 American has a coronary event, and approximately every 1 minute 23 seconds, an American will die of one.


Story Source:

The above story is based on materials provided by Louisiana State University Health Sciences Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. L. King, D. J. Polhemus, S. Bhushan, H. Otsuka, K. Kondo, C. K. Nicholson, J. M. Bradley, K. N. Islam, J. W. Calvert, Y.-X. Tao, T. R. Dugas, E. E. Kelley, J. W. Elrod, P. L. Huang, R. Wang, D. J. Lefer. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proceedings of the National Academy of Sciences, 2014; DOI: 10.1073/pnas.1321871111

Cite This Page:

Louisiana State University Health Sciences Center. "Heart attack research discovers new treatment target." ScienceDaily. ScienceDaily, 10 February 2014. <www.sciencedaily.com/releases/2014/02/140210161330.htm>.
Louisiana State University Health Sciences Center. (2014, February 10). Heart attack research discovers new treatment target. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2014/02/140210161330.htm
Louisiana State University Health Sciences Center. "Heart attack research discovers new treatment target." ScienceDaily. www.sciencedaily.com/releases/2014/02/140210161330.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins